Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission (Q44582792)
Jump to navigation
Jump to search
scientific article published in September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission |
scientific article published in September 2003 |
Statements
1 reference
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission (English)
1 reference
1 reference
Paschka P
1 reference
Müller MC
1 reference
Merx K
1 reference
Kreil S
1 reference
Schoch C
1 reference
Lahaye T
1 reference
Weisser A
1 reference
Petzold A
1 reference
König H
1 reference
Berger U
1 reference
Gschaidmeier H
1 reference
Hehlmann R
1 reference
1 September 2003
1 reference
1 reference
17
1 reference
9
1 reference
1687-1694
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference